Six stabs in the back of proton pump inhibitors

Proton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumati...

Full description

Saved in:
Bibliographic Details
Main Author: Andrei Evgenyevich Karateev
Format: Article
Language:Russian
Published: IMA PRESS LLC 2013-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1658
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399995195719680
author Andrei Evgenyevich Karateev
author_facet Andrei Evgenyevich Karateev
author_sort Andrei Evgenyevich Karateev
collection DOAJ
description Proton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumatic (above all nonsteroidal anti-inflammatory) drugs. PPIs are noteworthy for ease of use, efficacy, and excellent tolerability. Nevertheless, they are able to cause a number of serious class-specific adverse reactions. Some of these complications, such as osteoporosis progression and metabolic effect of methotrexate, may be of great importance for rheumatologic practice. This review is a critical analysis of the data available in the literature on the safety of PPIs and a risk-benefit assessment when they are used
format Article
id doaj-art-82c5609b1c274ca2aae4a0df87abf604
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2013-06-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-82c5609b1c274ca2aae4a0df87abf6042025-08-20T03:38:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922013-06-0151333234010.14412/1995-4484-2013-15091595Six stabs in the back of proton pump inhibitorsAndrei Evgenyevich KarateevProton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumatic (above all nonsteroidal anti-inflammatory) drugs. PPIs are noteworthy for ease of use, efficacy, and excellent tolerability. Nevertheless, they are able to cause a number of serious class-specific adverse reactions. Some of these complications, such as osteoporosis progression and metabolic effect of methotrexate, may be of great importance for rheumatologic practice. This review is a critical analysis of the data available in the literature on the safety of PPIs and a risk-benefit assessment when they are usedhttps://rsp.mediar-press.net/rsp/article/view/1658helicobacter pyloriproton pump inhibitorsadverse reactionsenteric infectionspneumoniahelicobacter pyloriosteoporosismethotrexateclopidogrel
spellingShingle Andrei Evgenyevich Karateev
Six stabs in the back of proton pump inhibitors
Научно-практическая ревматология
helicobacter pylori
proton pump inhibitors
adverse reactions
enteric infections
pneumonia
helicobacter pylori
osteoporosis
methotrexate
clopidogrel
title Six stabs in the back of proton pump inhibitors
title_full Six stabs in the back of proton pump inhibitors
title_fullStr Six stabs in the back of proton pump inhibitors
title_full_unstemmed Six stabs in the back of proton pump inhibitors
title_short Six stabs in the back of proton pump inhibitors
title_sort six stabs in the back of proton pump inhibitors
topic helicobacter pylori
proton pump inhibitors
adverse reactions
enteric infections
pneumonia
helicobacter pylori
osteoporosis
methotrexate
clopidogrel
url https://rsp.mediar-press.net/rsp/article/view/1658
work_keys_str_mv AT andreievgenyevichkarateev sixstabsinthebackofprotonpumpinhibitors